Evidence of off-label inhalation therapy on pediatric asthma practice in Japan.

Kenji OishiEisuke InageMayuki KojimaHiromichi YamadaYuko TanakaToshiyuki YoneyamaSusumu YamazakiAsuka HonjoYosuke Baba Takahiro KudoYoshikazu OhtsukaAkifumi EndoYosuke NakabayashiShoichi OyamaToshiaki Shimizu

Published in: Pediatrics international : official journal of the Japan Pediatric Society (2023)

There was a surprisingly large number of off-label prescriptions of asthma inhalers in the pediatric population in Japan. The proper use of ICSs/LABAs and expansion of insurance coverage should be advocated to reduce off-label use.

Keyphrases

chronic obstructive pulmonary disease
lung function
affordable care act
allergic rhinitis
primary care
healthcare
health insurance
stem cells
cell therapy